Reshoring
Enabling the Reshoring of Pharma Manufacturing with Integrated Continuous Manufacturing
Salvatore Mascia, Ph.D.; Bayan Takizawa
CONTINUUS Pharmaceuticals
PAO-08-25-CL-01Aug 08, 2025
Supply Chain
Future-Proofing a Volatile Supply Chain Through Modular Biomanufacturing
John Stewart; Rasmus Pedersen, Ph.D.; Peter Skals
Fujifilm Biotechnologies
PAO-06-25-CL-03Jul 07, 2025
Supply Chain
Labviva Automates Chemical Supply Chain for the Life Sciences Industry
Labviva
PR-06-25-NI-10Jun 26, 2025
DSCSA
Understanding the Drug Supply Chain Security Act
Leandro Moreira
Frontier Scientific Solutions
PAO-04-25-CL-05May 08, 2025
Supply Chain
Building Resilient Pharma Supply Chains in an Uncertain World
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-26Mar 31, 2025
Supply Chain
What strategies are ensuring supply chain resilience in a post-COVID world?
Pharma's Almanac
PAO-02-25-RT-02Feb 26, 2025
Appointment
Frontier Scientific Solutions Appoints Kevin Nash as President of European Operations
Frontier Scientific Solutions
PR-02-25-NI-22Feb 25, 2025
Product Stability
Reducing Tarmac Exposure to Enhance Biopharma Product Stability and Reduce Losses
Tony Yeates
Frontier Scientific Solutions
PAO-02-25-CL-03Feb 05, 2025
Cold Chain
Managing Temperature-Controlled Logistics for GLP-1 Drugs
Leandro Moreira
Frontier Scientific Solutions
PAO-02-25-CL-02Feb 05, 2025
Cell Therapy
From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials
Dominic Mancini
OrganaBio
PAO-01-25-CL-13Jan 28, 2025
Pharma
Impact of Strategic Location on Supply Chain Efficiency
Steven Uebele
Frontier Scientific Solutions
PAO-01-25-CL-03Jan 08, 2025
Foreign Trade
Economic and Environmental Benefits of Utilizing a Foreign Trade Zone
Michael Braddock II
Frontier Scientific Solutions
PAO-12-24-CL-6Jan 02, 2025
Supply Chain
Frontier Scientific Solutions Unveils Plans for a Trade Zone Gateway Dedicated for Life Sciences Supply Chain
Frontier Scientific Solutions
PR-10-24-NI-98Nov 15, 2024
BIOSECURE Act
Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?
Pharma's Almanac
PAO-11-24-RT-01Oct 28, 2024
Cell Therapy
Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
Justin Irizarry, CFA
OrganaBio
PAO-09-24-CL-11Sep 30, 2024
Biosimilars
Biosimilars: Manufacturing and Supply Chain for Worldwide Patients
Paula Olcese
Biosidus
PAO-08-24-CL-06Aug 07, 2024
Cell and Gene Therapy
Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Erin Schaller; Aidan Jones
PPD clinical research business of Thermo Fisher Scientific
PAO-06-24-CL-11Jul 09, 2024
Supply Chain
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
Tim Tyson; Jesse McCool, Ph.D.; Russell Harris; Yongkwan Ma
TriRx Pharmaceutical Services
PTV-12-23-CL-02Dec 12, 2023
Allogeneic Cell Therapy Logistics
Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement
Joy Aho, Ph.D.
Be The Match BioTherapies
PAO-06-23-CL-06Jun 27, 2023
Consulting
Supporting Drug Development – Increasing Probability of Success
Nick Davies; Beth Lindsey; Ian Smart
Verta Life Sciences
PAO-03-23-CL-04Mar 24, 2023